PRERISK
PRERISK: A Personalized, Artificial Intelligence–Based and Statistically–Based Stroke Recurrence Predictor for Recurrent Stroke
Clinical Question
Can routinely collected clinical and socioeconomic data be used to build accurate statistical and machine-learning models (PRERISK) that predict early, late, and long-term stroke recurrence in individual patients after a first-ever stroke?
Bottom Line
In a large, population-based cohort, PRERISK machine-learning models achieved AUROC 0.76 (early), 0.60 (late), and 0.71 (long-term) and outperformed Cox regression; a simplified model using key predictors had similar performance.
Major Points
- Population-based dataset: 41,975 stroke admissions from 88 public health centers (Catalonia, 2014–2020); analysis cohort 36,118 first-ever IS/ICH cases; 16.21% (5,932/36,114) had recurrence
- Outcomes predicted at three windows: early (≤90 days), late (91–365 days), long-term (>365 days)
- Model performance (ML AUROC): 0.76 (95% CI 0.74–0.77) early; 0.60 (0.58–0.61) late; 0.71 (0.69–0.72) long-term
- Comparator performance (Cox AUROC): 0.73 (0.72–0.75) early; 0.59 (0.57–0.61) late; 0.67 (0.66–0.70) long-term
- Key predictors: time since previous stroke, Barthel Index, atrial fibrillation, dyslipidemia, age, diabetes, sex; simplified model with modifiable risk factors showed similar accuracy
- Median follow-up was 2.69 years
Design
Study Type: Population-based cohort analysis with statistical (Cox) and supervised machine-learning models
Randomization:
Enrollment Period: 2014–2020
Follow-up Duration: Median 2.69 years
Centers: 88
Countries: Spain
Sample Size: 36114
Analysis: Supervised ML (Random Forest, AdaBoost, XGBoost) compared to Cox regression; performance assessed by AUROC/C-statistic; permutation importance for predictor contribution
Inclusion Criteria
- First-ever ischemic stroke (IS) or intracerebral hemorrhage (ICH) identified via ICD-9/10 codes
- Admission within the Catalonia public healthcare system (2014–2020)
- Survival ≥7 days after index stroke
Exclusion Criteria
- Transient ischemic attack (TIA) not included in analysis cohort
- Death within 7 days of index stroke
- Recurrent stroke diagnoses within 24 hours of index event (considered fluctuation, not recurrence)
Baseline Characteristics
| Characteristic | Control | Active |
|---|
Arms
| Field | Population-based cohort |
|---|---|
| Intervention | Supervised machine-learning models (Random Forest, AdaBoost, XGBoost) and Cox regression applied to routinely collected clinical + socioeconomic data to predict early (≤90 d), late (91–365 d), and long-term (>365 d) stroke recurrence. |
| Duration | Up to long-term follow-up (>1 year) |
Outcomes
| Outcome | Type | Control | Intervention | HR / OR / RR | P-value |
|---|---|---|---|---|---|
| Discrimination (AUROC) for prediction of stroke recurrence at early (≤90 d), late (91–365 d), and long-term (>365 d) windows | Primary | Cox AUROC: 0.73 (0.72–0.75); 0.59 (0.57–0.61); 0.67 (0.66–0.70) | ML AUROC: 0.76 (0.74–0.77); 0.60 (0.58–0.61); 0.71 (0.69–0.72) | ||
| Recurrence proportion and follow-up | Secondary | 16.21% (5,932/36,114) recurrences; median follow-up 2.69 years | |||
| Predictor importance (modifiable risk factors) | Secondary | Modifiable risk factors accounted for ~16%–39% of permutation importance across ML models | |||
| Retrospective model-building study | Adverse | Retrospective AI-based recurrence prediction study - no AE data |
Subgroup Analysis
A simplified model using key predictors (time since stroke, Barthel Index, AF, dyslipidemia, age, diabetes, sex) achieved similar performance to full ML models.
Criticisms
- Observational design using administrative/registry data susceptible to coding and selection bias
- Late-window performance (AUROC 0.60) indicates modest discriminative ability
- Generalizability may be limited to similar healthcare systems and data availability
Funding
Fundación Instituto Carlos III (PI20/01768); Ministerio de Asuntos Económicos y Transformación Digital (MIA.2021.M02.0005); European Commission (as listed in the article).
Based on: PRERISK (Stroke, 2024)
Authors: Giorgio Colangelo, DS, PhD; Marc Ribo, ..., PhD; Marta Rubiera
Citation: Stroke. 2024;55:1200–1209. DOI: 10.1161/STROKEAHA.123.043691
Content summarized and formatted by NeuroTrials.ai.